I am a breastfeeding mother and i want to know if it is safe to use CCRIS 3275? Is CCRIS 3275 safe for nursing mother and child? Does CCRIS 3275 extracts into breast milk? Does CCRIS 3275 has any long term or short term side effects on infants? Can CCRIS 3275 influence milk supply or can CCRIS 3275 decrease milk supply in lactating mothers?
- DrLact safety Score for CCRIS 3275 is 7 out of 8 which is considered Dangerous as per our analyses.
- A safety Score of 7 indicates that usage of CCRIS 3275 may cause toxic or severe side effects in breastfed baby.
- Our study of different scientific research indicates that CCRIS 3275 may cause moderate to high side effects or may affect milk supply in lactating mother.
- Our suggestion is to use safer alternate options rather than using CCRIS 3275 .
- Usage of CCRIS 3275 is in contradiction to breastfeeding hence if it is must to use CCRIS 3275 and there is no better alternative available then breastfeeding shall be stopped permanently or temporarily.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Anti-estrogen drug with anticancer effects. May inhibit lactation. It is not safe for the mother to continue BF whenever a risk of residual tumor is likely, which actually has been the reason for using this drug. Once any risk had disappeared (later on, or after a future pregnancy) it is convenient to resume BF.
Since CCRIS 3275 can suppress postpartum lactation and its excretion into breastmilk is not known, it should be avoided in nursing mothers.
CCRIS 3275 was more effective than placebo in suppressing lactation and preventing engorgement and pain in two trials in postpartum mothers. Neither study stated what, if any, physical methods (e.g., breast binding) were used concurrently.[1][2] In one study of 80 women, CCRIS 3275 10 mg four times daily for 5 days was more effective than placebo in suppressing a rise in serum prolactin after use of a mechanical breast pump after 5 days of treatment, but not on day 3. All of the women in the study had breastfed a previous child.[2] The other study of 150 women used 2 regimens: CCRIS 3275 30 mg twice daily for 2 days followed by 10 mg twice daily for 2 days; and 10 mg twice daily for 14 days. More women in the CCRIS 3275 groups had not previously breastfed an infant.[1] In a case report, a woman with a history of breastfeeding 4 children (the last having been weaned 10 months earlier) began lactating after 1 week of a cancer chemotherapy regimen for breast cancer that included CCRIS 3275 20 mg/day. Milk production continued for several weeks until CCRIS 3275 was discontinued after which it did not return during 12 more weeks of chemotherapy.[3]
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.